β-N-methylamino-l-alanine induced in vivo retinal cell death

Journal of Neurochemistry

Volumn 109, Issue 3, 2009, Pages 819-825

  Santucci, Serena ^a   Zsürger, Nicole ^a   Chabry, Joëlle ^a  

^a CNRS   (France)

Author keywords

N methylamino l alanine; Amyotrophic lateral sclerosis Parkinson dementia complex; Electroretinography; Neurodegeneration; NMDA; Retina

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; CASPASE 3; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA CELL;

AMINO ACIDS, DIAMINO; ANIMALS; CASPASE 3; CELL DEATH; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROOCULOGRAPHY; EVOKED POTENTIALS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; NEURONS; PROPIDIUM; REACTIVE OXYGEN SPECIES; RETINA; TIME FACTORS;

CYANOBACTERIA; CYCAS CIRCINALIS;

EID: 64149132731     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06022.x     Document Type: Article

References (20)

1. Allen C. N., Omelchenko I., Ross S. M. Spencer P. (1995) The neurotoxin, ß-N-methylamino-L-alanine (BMAA) interacts with the strychnine-insensitive glycine modulatory site of the N-methyl-D-aspartate receptor. Neuropharmacology 34, 651 658.
2. Banack S. A. Cox P. A. (2003) Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology 61, 387 389.
3. Bergström A. L., Cordes H., Zsurger N., Heegaard P. M., Laursen H. Chabry J. (2005) Amidation and structure relaxation abolish the neurotoxicity of the prion peptide PrP106-126 in vivo and in vitro. J. Biol. Chem. 280, 23114 23121.
4. Blanks J. C., Hinton D. R., Sadun A. A. Miller C. A. (1989) Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res. 501, 364 372.
5. Buenz E. J. Howe C. L. (2007) ß-methylamino-alanine (BMAA) injures hippocampal neurons in vivo. Neurotoxicology 28, 702 704.
6. Cox T. A., McDarby J. V., Lavine L., Steele J. C. Calne D. B. (1989) A retinopathy on Guam with high prevalence in Lytico-Bodig. Ophthalmology 96, 1731 1735.
7. Cox P. A., Banack S. A. Murch S. J. (2003) Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc. Natl. Acad. Sci. USA 100, 13380 13383.
8. Cox P. A., Banack S. A., Murch S. J., Rasmussen U., Tien G., Bidigare R. R., Metcalf J. S., Morrison L. F., Codd G. A. Bergman B. (2005) Diverse taxa of cyanobacteria produce ß-N-methylamino-L-alanine, a neurotoxic amino acid. Proc. Natl. Acad. Sci. USA 102, 5074 5078.
9. Cruz-Aguado R., Winkler D. Shaw C. A. (2006) Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice. Pharmacol. Biochem. Behav. 84, 294 299.
10. Duncan M. W. (1991) Role of the cycad neurotoxin BMAA in the amyotrophic lateral sclerosis-parkinsonism dementia complex of the western Pacific. Adv. Neurol. 56, 301 310.
11. Lamas M., Lee-Rivera I. Lopez-Colome A. M. (2005) Cell-specific expression of N-methyl-D-aspartate receptor subunits in Muller glia and neurons from the chick retina. Invest. Ophthalmol. Vis. Sci. 46, 3570 3577.
12. Lindstrom H., Luthman J., Mouton P., Spencer P. Olson L. (1990) Plant-derived neurotoxic amino acids (ß-N-oxalylamino-L-alanine and ß-N-methylamino-L-alanine): effects on central monoamine neurons. J. Neurochem. 55, 941 949.
13. Lobner D., Piana P. M., Salous A. K. Peoples R. W. (2007) Beta-N-methylamino-l-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol Dis 25, 360 366.
14. Montine T. J., Li K., Perl D. P. Galasko D. (2005) Lack of ß-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology 65, 768 769.
15. Murch S. J., Cox P. A. Banack S. A. (2004a) A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc. Natl. Acad. Sci. USA 101, 12228 12231.
16. Murch S. J., Cox P. A., Banack S. A., Steele J. C. Sacks O. W. (2004b) Occurrence of ß-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol. Scand. 110, 267 269.
17. Perry T. L., Bergeron C., Biro A. J. Hansen S. (1989) ß-N-methylamino-L-alanine. Chronic oral administration is not neurotoxic to mice. J. Neurol. Sci. 94, 173 180.
18. Rao S. D., Banack S. A., Cox P. A. Weiss J. H. (2006) BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp. Neurol. 201, 244 252.
19. Spencer P. S., Nunn P. B., Hugon J., Ludolph A. C., Ross S. M., Roy D. N. Robertson R. C. (1987) Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237, 517 522.
20. Zeevalk G. D. Nicklas W. J. (1989) Acute excitotoxicity in chick retina caused by the unusual amino acids BOAA and BMAA: effects of MK-801 and kynurenate. Neurosci. Lett. 102, 284 290.